A recent study found that patients younger than the onset of diabetes had a significant association with a higher risk of subsequent dementia.Researchers led...
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...